Table I.
Baseline characteristics of the study population (n=134).
| Characteristic | Acarbose + | Acarbose − | P-value |
|---|---|---|---|
| Patients (n) | 68 | 66 | – |
| Gender (male/female) | 35/33 | 32/34 | – |
| Age (years) | 65.75±4.35 | 66.33±7.66 | 0.926 |
| Body weight (kg) | 60.15±10.33 | 62.15±10.86 | 0.845 |
| Body mass index (kg/m2) | 23.63±3.93 | 24.23±2.21 | 0.729 |
| HbA1c (%) | 9.66±1.90 | 9.79±1.19 | 0.721 |
Acarbose +, acarbose add-on insulin therapy group; Acarbose -, insulin monotherapy group. HbA1c, haemoglobin A1c. Data are presented as means ± standard deviation.